Quest Diagnostics Inc (DGX)
Sector: Healthcare
Industry: Services-Medical Laboratories
Country: United States
Exchange: NYSE
Market cap: $27.31B
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Latest financial period: June 30, 2026
Filed with the SEC: July 23, 2026
Estimated earnings date: October 20, 2026
Profit #726 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROIC | 9.9% | 9.6% | 9.4% | 9.2% |
Growth #707 of 1484 companies
Payout #590 of 1484 companies
Safety #181 of 1484 companies
Price #657 of 1484 companies
